Louria Hayon Igal - Insider Non-Derivative Transactions at Raphael Pharmaceutical Inc. (RAPH) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Aug 29, 2023, Louria Hayon Igal's relationship to Raphael Pharmaceutical Inc. (RAPH) is Director,Officer (Chief Technology Officer), and currently has 999,000 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other RAPH insiders.
Data Source: SEC.
Louria Hayon Igal - Insider Non-Derivative Transactions at RAPH
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Aug 30, 2023 | X -- (Common Stock) | 999000 | 0.01 | 999000 |